Thousands are living with Parkinson's undiagnosed and unsupported, our new research finds
Date
Research news
Date
Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Date
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Date
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
Date
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
Date
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Date
Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
Date
A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Date
Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
Date
In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
Date
Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.